STAAR Surgical Generates $464,000 in Cash from Operations During Thi...(--- --- Net cash u...),Health

Date:11/2/2009

--- --- Net cash used in operating activities 302 (7,237) --- ------ Cash flows from investing activities: Cash acquired in acquisition of Canon Staar, net of acquisition costs - 2,215 Acquisition of property and equipment (320) (802) Proceeds from sale of property and equipment 160 100 Purchase of short-term investments (22) - Proceeds from sale of short-term investments 190 - Restricted deposit with the Superior Court of Orange County (7,368) - Net change in other assets 5 149 -- --- Net cash provided by (used in) investing activities (7,355) 1,662 ------ ----- Cash flows from financing activities: Borrowings under lines of credit 630 3,760 Repayments of lines of credit (630) (1,880) Repayment of capital lease lines of credit (852) (762) Net proceeds of public sale of equity securities 8,548 - Proceeds from the exercise of stock options - 40 -- -- Net cash provided by financing activities 7,696 1,158 ----- ----- Effect of exchange rate changes on cash and cash eq
'/>"/>

SOURCE STAAR Surgical Company Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Related medicine technology :

1. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
2. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
6. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
7. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
10. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery